|
1
|
Cortini M, Avnet S and Baldini N:
Mesenchymal stroma: Role in osteosarcoma progression. Cancer Lett.
405:90–99. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yu W, Tang L, Lin F, Yao Y, Shen Z and
Zhou X: The role of chemotherapy for metastatic, relapsed and
refractory osteosarcoma. Surg Oncol. 1:9–15. 2015. View Article : Google Scholar
|
|
3
|
Bartonicek N, Maag JL and Dinger ME: Long
noncoding RNAs in cancer: Mechanisms of action and technological
advancements. Mol Cancer. 15:432016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lavorgna G, Vago R, Sarmini M, Montorsi F,
Salonia A and Bellone M: Long non-coding RNAs as novel therapeutic
targets in cancer. Pharmacol Res. 110:131–138. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang CF and Zhu XZ: The fourth edition of
WHO classification of tumours of bone: An introduction. Zhonghua
Bing Li Xue Za Zhi. 10:652–654. 2013.(In Chinese).
|
|
6
|
Xue M, Li X, Wu W, Zhang S, Wu S, Li Z and
Chen W: Upregulation of long non-coding RNA urothelial carcinoma
associated 1 by CCAAT/enhancer binding protein α contributes to
bladder cancer cell growth and reduced apoptosis. Oncol Rep.
5:1993–2000. 2014. View Article : Google Scholar
|
|
7
|
Yang MH, Hu ZY, Xu C, Xie LY, Wang XY,
Chen SY and Li ZG: MALAT1 promotes colorectal cancer cell
proliferation/migration/invasion via PRKA kinase anchor protein 9.
Biochim Biophys Acta. 1852:166–174. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li J, Wang J, Chen Y, Li S, Jin M, Wang H,
Chen Z and Yu W: LncRNA MALAT1 exerts oncogenic functions in lung
adenocarcinoma by targeting miR-204. Am J Cancer Res. 6:1099–1107.
2016.PubMed/NCBI
|
|
9
|
Miao Y, Fan R, Chen L and Qian H: Clinical
significance of long Non-coding RNA MALAT1 expression in tissue and
serum of breast cancer. Ann Clin Lab Sci. 46:418–424.
2016.PubMed/NCBI
|
|
10
|
Zhou Y, Xu X, Lv H, Wen Q, Li J, Tan L, Li
J and Sheng X: The long noncoding RNA MALAT-1 is highly expressed
in ovarian cancer and induces cell growth and migration. PLoS One.
11:e01552502016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lai MC, Yang Z, Zhou L, Zhu QQ, Xie HY,
Zhang F, Wu LM, Chen LM and Zheng SS: Long non-coding RNA MALAT-1
overexpression predicts tumor recurrence of hepatocellular
carcinoma after liver transplantation. Med Oncol. 29:1810–1816.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cai B, Song XQ, Cai JP and Zhang S:
HOTAIR: A cancer-related long non-coding RNA. Neoplasma.
64:379–391. 2014. View Article : Google Scholar
|
|
13
|
Wu Y, Zhang L, Zhang L, Wang Y, Li H, Ren
X, Wei F, Yu W, Liu T, Wang X, et al: Long non-coding RNA HOTAIR
promotes tumor cell invasion and metastasis by recruiting EZH2 and
repressing E-cadherin in oral squamous cell carcinoma. Int J Oncol.
46:2586–2594. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee NK, Lee JH, Park CH, Yu D, Lee YC,
Cheong JH, Noh SH and Lee SK: Long non-coding RNA HOTAIR promotes
carcinogenesis and invasion of gastric adenocarcinoma. Biochem
Biophys Res Commun. 45:171–178. 2014. View Article : Google Scholar
|
|
15
|
Gupta RA, Shah N, Wang KC, Kim J, Horlings
HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, et al: Long
non-coding RNA HOTAIR reprograms chromatin state to promote cancer
metastasis. Nature. 464:1071–1076. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang Z, Cheng J, Wu Y, Qiu J, Sun Y and
Tong X: LncRNA HOTAIR controls the expression of Rab22a by sponging
miR-373 in ovarian cancer. Mol Med Rep. 14:2465–2472. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang G, Cui T, Sun L, Peng N and Yang C:
Long noncoding RNA LeXis promotes osteosarcoma growth through
upregulation of CTNNB1 expression. Am J Cancer Res. 7:1577–1587.
2017.PubMed/NCBI
|
|
19
|
Li Z, Dou P, Liu T and He S: Application
of long noncoding RNAs in osteosarcoma: Biomarkers and therapeutic
targets. Cell Physiol Biochem. 42:1407–1419. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li Z, Zhao L and Wang Q: Overexpression of
long non-coding RNA HOTTIP increases chemoresistance of
osteosarcoma cell by activating the Wnt/β-catenin pathway. Am J
Transl Res. 8:2385–2393. 2016.PubMed/NCBI
|
|
21
|
Li W, Xie P and Ruan WH: Overexpression of
lncRNA UCA1 promotes osteosarcoma progression and correlates with
poor prognosis. J Bone Oncol. 5:80–85. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xue X, Yang YA, Zhang A, Fong KW, Kim J,
Song B, Li S, Zhao JC and Yu J: LncRNA HOTAIR enhances ER signaling
and confers tamoxifen resistance in breast cancer. Oncogene.
35:2746–2755. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sun X, Du P, Yuan W, Du Z, Yu M, Yu X and
Hu T: Long non-coding RNA HOTAIR regulates cyclin J via inhibition
of microRNA-205 expression in bladder cancer. Cell Death Dis.
6:e19072015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xue Y, Gu D, Ma G, Zhu L, Hua Q, Chu H,
Tong N, Chen J, Zhang Z and Wang M: Genetic variants in lncRNA
HOTAIR are associated with risk of colorectal cancer. Mutagenesis.
30:303–310. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang B, Su Y, Yang Q, Lv D, Zhang W, Tang
K, Wang H, Zhang R and Liu Y: Overexpression of long Non-coding RNA
HOTAIR promotes tumor growth and metastasis in human osteosarcoma.
Mol Cells. 38:432–440. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Takahashi-Yanaga F and Sasaguri T:
GSK-3beta regulates cyclin D1 expression: A new target for
chemotherapy. Cell Signal. 20:581–589. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sheaff RJ, Groudine M, Gordon M, Roberts
JM and Clurman BE: Cyclin E-CDK2 is a regulator of p27Kip1. Genes
Dev. 11:1464–1178. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yue J, Zhang K and Chen J: Role of
integrins in regulating proteases to mediate extracellular matrix
remodeling. Cancer Microenviron. 5:275–283. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yu Q and Stamenkovic I: Localization of
matrix metalloproteinase 9 to the cell surface provides a mechanism
for CD44-mediated tumor invasion. Genes Dev. 13:35–48. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Canel M, Serrels A, Frame MC and Brunton
VG: E-cadherin-integrin crosstalk in cancer invasion and
metastasis. J Cell Sci. 126:393–401. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang P, Qiu Z, Jiang Y, Dong L, Yang W, Gu
C, Li G and Zhu Y: Silencing of cZNF292 circular RNA suppresses
human glioma tube formation via the Wnt/β-catenin signaling
pathway. Oncotarget. 7:63449–63455. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sokolowski KM, Koprowski S, Kunnimalaiyaan
S, Balamurugan M, Gamblin TC and Kunnimalaiyaan M: Potential
molecular targeted therapeutics: Role of PI3-K/AKT/mTOR inhibition
in cancer. Anticancer Agents Med Chem. 16:29–37. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tan J, Jiang X, Yin G, He L, Liu J, Long
Z, Jiang Z and Yao K: Anacardic acid induces cell apoptosis of
prostatic cancer through autophagy by ER stress/DAPK3/Akt signaling
pathway. Oncol Rep. 38:1373–1382. 2017.PubMed/NCBI
|
